TCRLAS v2.0 · HUMAN REVIEW

A decision about the next step.

Commercialization Decision Assessment (CDA) records a named human review for a defined next action.

Working methodology, not externally validated. These guides organize review; they do not verify evidence, authenticate reviewers or issue investment, medical or regulatory certifications.
01

Verify the assessment

Record independently evidenced TCRLAS, CVA, HSE when relevant, scope, jurisdiction and dated sources.

02

Screen the proposed action

Identify blockers affecting this milestone; distinguish restrictions on launch from lawful preparatory work.

03

Evaluate opportunity and execution

Review economics, resources, owners, alternative routes and opportunity costs.

04

Record the reviewer’s choice

ADVANCE a bounded milestone; IMPROVE a remediable gap; PIVOT the route; HOLD for specified evidence; or STOP the evaluated route.

05

Make the next milestone accountable

Document cost ceiling, owner, deadline, success test, review date, rationale and any dissent. ADVANCE does not authorize launch.

Use the general CVA or healthcare assessment page to record evidence, blockers, decisions and launch requirements. Export the complete JSON before leaving the page; records are not automatically saved.